ClinicalTrials.gg
Not yet recruitingNCT07782047Updated Aug 24, 2026

Assistive Device Rental/Purchase, LTC Service Use, and Caregiver Burden in Taiwan

An observational study in Self-Help Devices, Long-Term Care and Caregiver Burden, sponsored by National Health Research Institutes, Taiwan. Not yet recruiting at 1 site in Taiwan. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by National Health Research Institutes, Taiwan · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
161,771
Sex
All
01

Study summary

The goal of this observational study is to examine the associations between assistive device approval and acquisition modality (rental or purchase), long-term care service utilization, and family caregiver burden among individuals receiving long-term care services in Taiwan. The study will use de-identified nationwide long-term care administrative data from 2021 to 2022.

The main questions it aims to answer are:

  1. What individual, disability-related, socioeconomic, residential, and caregiving factors are associated with assistive device approval, the number and type of approved devices, and rental or purchase modality?
  2. Are assistive device approval and utilization patterns associated with the use of formal long-term care services and with family caregiver burden?
02

Conditions studied

  • Self-Help Devices
  • Long-Term Care
  • Caregiver Burden
  • Health Services Research

Browse trials for

03

In context

Caregiver Burden

500 studies on the registry are indexed under Caregiver Burden; 164 are open to participants now.

This study's planned enrollment of 161,771 is above the median of 100 across 80 observational studies indexed under Caregiver Burden.

Browse Caregiver Burden studies →

Lead sponsor

National Health Research Institutes, Taiwan is the lead sponsor of 128 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of individuals represented in Taiwan's nationwide long-term care administrative databases from 2021 to 2022. Eligible individuals must have a valid long-term care case record (CA100) and at least one valid linked assessment or care plan record (CA110). De-identified records will be used to examine assistive device approval and acquisition patterns, long-term care service utilization, and family caregiver-related characteristics and burden. No participants will be directly recruited or contacted.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals with a valid long-term care case record (CA100) in Taiwan's long-term care database between 2021 and 2022.
  • Individuals with at least one valid assessment or care plan record (CA110) that can be linked to the corresponding CA100 record.
  • Availability of interpretable key study variables, including individual and assessment/care plan identifiers, care plan status, and Case-Mix System (CMS) level or other core disability-related information.
  • For analyses of assistive device utilization, the presence or absence of an assistive device record (QD113) and its approval status must be identifiable.

Exclusion criteria

Exclusion Criteria:

  • Records with missing key linkage variables that prevent establishment of relationships among individuals, care plans, assistive device records, or service utilization records.
  • Records identified as invalid, cancelled, test records, or records whose validity cannot be determined.
  • Records in which primary study variables cannot be interpreted.
  • Records with clearly implausible values for variables such as individual age, caregiver age, CMS level, number of assistive devices, or service utilization that cannot be corrected according to prespecified data-cleaning rules.
  • Records with inconsistent or contradictory date information that prevents valid determination of an index date or observation period.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
161,771 participants (estimated)
Patient registry
No

Groups and cohorts

  • Assistive device approved

    Participants who was approved the assistive devise in nationwide long-term care administrative data in Taiwan

  • No assistive device approved

    Participants who was not approved the assistive devise in nationwide long-term care administrative data in Taiwan

06

What researchers measure

Primary outcomes

  1. Assistive Device Approval Status

    Whether an individual had an approved assistive device record, determined using the approval status recorded in the Assistive Technology File (QD113). Associations with disability severity, sociodemographic characteristics, residential characteristics, and caregiving conditions will be examined.

    Time frame: During the 2021-2022 observation period

  2. Formal Long-Term Care Service Utilization

    Utilization of formal long-term care services, including total service utilization and category-specific utilization of care services, professional services, transportation, respite care, meal services, and other long-term care services. Associations with assistive device approval, number of devices, acquisition modality, and device category will be examined.

    Time frame: During the 2021-2022 observation period

  3. Family Caregiver Burden

    Family caregiver burden will be assessed using available administrative-record indicators, including sleep disturbance, physical burden, competing caregiving demands, distress related to care-recipient behaviors, and inability to cope with caregiving stress. A cumulative caregiver burden indicator will also be derived from the number of burden items endorsed.

    Time frame: During the 2021-2022 observation period

Secondary outcomes

  1. Assistive Device Acquisition Modality

    Acquisition modality of approved assistive devices, categorized as rental or purchase according to the Assistive Technology File (QD113) administrative record. Factors associated with rental versus purchase will be examined.

    Time frame: During the 2021-2022 observation period

  2. Number and Category of Approved Assistive Devices

    Number of approved assistive devices and device categories, such as mobility, transfer, bathing and toileting, home-care beds and bedside equipment, safety or monitoring devices, and communication or cognitive support devices.

    Time frame: During the 2021-2022 observation period

07

Study locations

1 site
  • National Center for Geriatrics and Welfare Research, National Health Research Institutes
    Huwei, Yunlin County 632007, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07782047
Responsible party
Sponsor
First posted
Aug 24, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Aug 31, 2028 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Aug 24, 2026

Study contacts

Kai-Chia Cheng, PhD
Contact
kccheng@nhri.edu.tw
+886-5-6204000 ext. 51169
Yu-Chi Chen, MS
Contact
irene.chen@nhri.edu.tw
+886-5-6204000 ext. 51251
Chueh-Ho Lin, PhD
principal investigator · National Health Research Institutes, Taiwan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion